Johnson & Johnson

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$71,890
Revenue Growth (%)2.59%
Net Income (US$ Millions)$16,540
Earnings Per Share (US$)$5.93
EPS Growth Rate (%)8.21%
Profit Margin23.01%
Total Equity (US$ Millions)$70,418
Return on Equity (%)23.25%
Long Term Debt (US$ Millions)$22,442
Debt To Equity Ratio (%)0.32%
Total Assets (US$ Millions)$141,208
Current Assets (US$ Millions)$65,032
Current Liabilities (US$ Millions)$26,287
Cost of Goods Sold (US$ Millions)$21,685
Inventory Turnover2.68